Digital Technologies Supporting Treatment Adherence in Tuberculosis in Ukraine 2018—2025: Programmatic Analysis of the Implementation of Smart Pill Boxes and Video-Supported Treatment
Tuberculosis, Lung Diseases, HIV Infection · 11.05.2026 · (2) · 11-17
DOI: 10.30978/tb2026-2-11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis, Lung Diseases, HIV Infection, online erschienen am 11.05.2026. Verfasst von V.I. Kochanov und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Objective — to assess the experience of programmatic implementation of digital adherence technologies (DAT) for tuberculosis treatment in Ukraine during 2018—2025 within the Support TB Control Efforts in Ukraine (STBCEU) project, funded by the U.S. Government and implemented by PATH in collaboration with the National Tuberculosis Programme, including an analysis of coverage, treatment outcomes, use under full-scale war conditions, and prospects for further integration and sustainability. Materials and methods. A retrospective descriptive analysis of aggregated programmatic data from the Everwell Hub platform (2021—2025) and DAT implementation reports for 2018—2025 was conducted. The intervention included the use of evriMED smart pill boxes and video-supported therapy (VST) delivered through the SureAdhere application (until 2024) and Hub Health Companion (since 2024). Data were analysed using descriptive methods. Results and discussion. Between 2018 and 2025, DAT were implemented in 11 oblasts of Ukraine. In total, 6,245 people with TB used digital adherence technologies, including 5,345 patients registered in the Everwell Hub system during the scale-up period supported by the project. Among those registered, 5,295 received treatment for active TB and 50 received tuberculosis preventive treatment (TPT). In 2024—2025, 1,731 DAT users completed treatment, of whom 90 % achieved successful treatment outcomes. Treatment success rates among smart pill box users were 93.1 % for drug-susceptible TB and 86.7 % for drug-resistant TB; among VST users, success rates were 90.9 and 94.6 %, respectively. DAT were also used to monitor tuberculosis preventive treatment in Kirovohradska oblast. Conclusions. The scale-up of DAT in Ukraine demonstrated the feasibility of integrating digital tools into routine tuberculosis care. Ensuring the sustainability of the intervention will require full integration into national information systems, optimisation of workflows and the provision of long-term financing.
Zitieren
APA
Kochanov, V., Bogdanov, O., Germanovych, M., Gorenko, G., Gamazina, K., & Dravniece, G. (2026). Digital Technologies Supporting Treatment Adherence in Tuberculosis in Ukraine 2018—2025: Programmatic Analysis of the Implementation of Smart Pill Boxes and Video-Supported Treatment. Tuberculosis, Lung Diseases, HIV Infection, 11-17. https://doi.org/10.30978/tb2026-2-11
Vancouver
Kochanov V, Bogdanov O, Germanovych M, Gorenko G, Gamazina K, Dravniece G. Digital Technologies Supporting Treatment Adherence in Tuberculosis in Ukraine 2018—2025: Programmatic Analysis of the Implementation of Smart Pill Boxes and Video-Supported Treatment. Tuberculosis, Lung Diseases, HIV Infection. 2026:11-17. doi:10.30978/tb2026-2-11
BibTeX
@article{Kochanov2026,
author = {Kochanov, V.I. and Bogdanov, O.V. and Germanovych, M.I. and Gorenko, G.O. and Gamazina, K.O. and Dravniece, G.},
title = {Digital Technologies Supporting Treatment Adherence in Tuberculosis in Ukraine 2018—2025: Programmatic Analysis of the Implementation of Smart Pill Boxes and Video-Supported Treatment},
journal = {Tuberculosis, Lung Diseases, HIV Infection},
year = {2026},
number = {2},
pages = {11--17},
doi = {10.30978/tb2026-2-11}
}
EUVIMED